Effects of vitamin D metabolites and bisphosphonates on fibronectin release from monocyte-derived macrophages.
Fibronectin release from cultured macrophages, derived from human blood monocytes, was measured during incubation of the cells with increasing concentrations of vitamin D3 metabolites or of aminobutane bisphosphonate (AHButBP) or dichloromethylene bisphosphonate (Cl2MBP), two powerful inhibitors of bone resorption. The bisphosphonates significantly inhibited fibronectin release at 10(-8) M concentration and this inhibition was almost complete at 10(-5) M concentration. Opposite results were observed when the cells were incubated with vitamin D3 metabolites: the stimulation of fibronectin release was specific for 1,25-dihydroxyvitamin D3 relative to other vitamin D3 metabolites (1,25-dihydroxyvitamin D3 greater than 25-hydroxyvitamin D3 greater than 24,25-dihydroxyvitamin D3).
Mian
M
M
Department of Pharmacology, University of Milan, Italy.
Adami
S
S
Rigo
A
A
Bonazzi
L
L
Braga
V
V
Lo Cascio
V
V
D015650:24,25-Dihydroxyvitamin D 3 / Q000494:pharmacology; D000328:Adult; D002117:Calcitriol / Q000378:metabolism / Q000494:pharmacology; D002478:Cells, Cultured; D004002:Clodronic Acid / Q000494:pharmacology*; D004164:Diphosphonates / Q000494:pharmacology*; D004797:Enzyme-Linked Immunosorbent Assay; D005353:Fibronectins / Q000378:metabolism*; D006801:Humans; D006887:Hydroxycholecalciferols / Q000494:pharmacology*; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism*
D004164:Diphosphonates; D005353:Fibronectins; D006887:Hydroxycholecalciferols; D004002:Clodronic Acid; C058568:aminobutane bisphosphonate; D015650:24,25-Dihydroxyvitamin D 3; D002117:Calcitriol